Ortivus AB

  • Market Cap: Micro Cap
  • Industry: Software Products
  • ISIN: SE0000123085
SEK
1.22
0.00 (0.00%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

N/A

Shareholding

FII

N/A

DII

N/A

Promoter

N/A

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Dashboard
1

With a Negative Book Value, the company has a Weak Long Term Fundamental Strength

  • High Debt Company with a Debt to Equity ratio (avg) at times
2

The company has declared Negative results for the last 10 consecutive quarters

3

Risky -

4

Consistent Underperformance against the benchmark over the last 3 years

stock-summaryMojo Parameters
Mojo Parameters
Stock DNA
stock-summary
Industry

Software Products

stock-summary
Market cap

SEK 47 Million (Micro Cap)

stock-summary
P/E

NA (Loss Making)

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

-2.75

stock-summary
Return on Equity

101.67%

stock-summary
Price to Book

-2.92

Revenue and Profits:
Net Sales:
20 Million
(Quarterly Results - Jun 2025)
Net Profit:
-6 Million
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
7.02%
0%
7.02%
6 Months
-18.39%
0%
-18.39%
1 Year
-25.84%
0%
-25.84%
2 Years
-66.94%
0%
-66.94%
3 Years
-77.07%
0%
-77.07%
4 Years
-76.03%
0%
-76.03%
5 Years
-75.55%
0%
-75.55%

Ortivus AB for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions
News
Icon
No Recent News for the Company
Announcements stock-summary
Icon
No announcement available
Corporate Actions stock-summary
Icon
No corporate action available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
-2.24%
EBIT Growth (5y)
-239.06%
EBIT to Interest (avg)
0.68
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-3.72
Sales to Capital Employed (avg)
2.92
Tax Ratio
0.15%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
58.09%
ROE (avg)
19.34%
Valuation key factors
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
-3.32
EV to EBIT
-17.05
EV to EBITDA
98.34
EV to Capital Employed
3.47
EV to Sales
1.25
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-20.37%
ROE (Latest)
Negative BV
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Mildly Bearish
Moving Averages
Mildly Bearish (Daily)
KST
Mildly Bullish
Mildly Bullish
Dow Theory
No Trend
No Trend
OBV
Mildly Bullish
Mildly Bullish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshotstock-summary
Icon
No data for shareholding present.
Shareholding Compare (%holding) stock-summary
Icon
No data for shareholding present.
stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Jun 2025 is 8.84% vs -15.02% in Mar 2025",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Jun 2025 is -170.83% vs 75.00% in Mar 2025",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Jun'25",
        "Mar'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "19.70",
          "val2": "18.10",
          "chgp": "8.84%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "0.50",
          "val2": "-1.10",
          "chgp": "145.45%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "1.20",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-6.50",
          "val2": "-2.40",
          "chgp": "-170.83%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-6.90%",
          "val2": "-131.00%",
          "chgp": "12.41%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2024 is -4.40% vs -19.52% in Dec 2023",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2024 is -34.62% vs -408.47% in Dec 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "80.40",
          "val2": "84.10",
          "chgp": "-4.40%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-7.90",
          "val2": "-13.30",
          "chgp": "40.60%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "5.30",
          "val2": "0.60",
          "chgp": "783.33%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "-8.50",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-24.50",
          "val2": "-18.20",
          "chgp": "-34.62%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-131.50%",
          "val2": "-195.00%",
          "chgp": "6.35%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQstock-summary
Jun'25
Mar'25
Change(%)
Net Sales
19.70
18.10
8.84%
Operating Profit (PBDIT) excl Other Income
0.50
-1.10
145.45%
Interest
1.20
0.00
Exceptional Items
0.00
0.00
Consolidate Net Profit
-6.50
-2.40
-170.83%
Operating Profit Margin (Excl OI)
-6.90%
-131.00%
12.41%
USD in Million.
Direction Arrows
Net Sales

QoQ Growth in quarter ended Jun 2025 is 8.84% vs -15.02% in Mar 2025

Direction Arrows
Consolidated Net Profit

QoQ Growth in quarter ended Jun 2025 is -170.83% vs 75.00% in Mar 2025

Annual Results Snapshot (Consolidated) - Dec'24stock-summary
Dec'24
Dec'23
Change(%)
Net Sales
80.40
84.10
-4.40%
Operating Profit (PBDIT) excl Other Income
-7.90
-13.30
40.60%
Interest
5.30
0.60
783.33%
Exceptional Items
-8.50
0.00
Consolidate Net Profit
-24.50
-18.20
-34.62%
Operating Profit Margin (Excl OI)
-131.50%
-195.00%
6.35%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in year ended Dec 2024 is -4.40% vs -19.52% in Dec 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Dec 2024 is -34.62% vs -408.47% in Dec 2023

stock-summaryCompany CV
About Ortivus AB stock-summary
stock-summary
Ortivus AB
Software Products
Ortivus AB is a Sweden-based provider of mobile solutions for modern emergency medical services. The Company is engaged in the development of mobile surveillance and communication solutions, forming a decision support system. Its offering comprises: MobiMed Smart, a decision support system, which allows ambulance personnel to handle documentation, monitoring and introduce a structured approach in prehospital care; CoroNet, a mobile surveillance solution which allows patients to move freely under supervision of medical staff and provides healthcare professionals with monitoring information. In addition, the Company provides a wide range of services, such as support, implementation, training and consulting, among others. The Company’s customer base includes mainly ambulance services and emergency departments.
Company Coordinates stock-summary
Company Details
Svardvagen 19 , DANDERYD None : 182 33
stock-summary
Tel: 46 8 4464500
stock-summary
Registrar Details